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Abstract
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Economic analyses of development projects and policies 
often involve assigning an economic value to changes in 
the risk of loss of human life. A typical term used in the 
economic analyses is the value of statistical life, which 
reflects the aggregation of individuals’ willingness to pay 
for fatal risk reduction and therefore the economic value 
to society to reduce the statistical incidence of premature 
death in the population by one. Studies on the value 
of a statistical life have been extensively conducted in 
the developed world; however, few such studies can be 
found for developing countries. This paper presents a 
study that estimates individuals’ willingness to pay for 
cancer risk prevention in three provinces of China. The 
results imply that the mean value of willingness to pay 
for a cancer vaccine that is effective for one year is 759 
yuan, with a much lower median value of 171 yuan. 
This paper—a product of the Environment and Energy Team, Development Research Group—is part of a larger effort in 
the department to understand and improve environmental governance in developing countries.. Policy Research Working 
Papers are also posted on the Web at http://econ.worldbank.org. The author may be contacted at hwang1@worldbank.org.  
The estimated income elasticity of willingness to pay is 
0.42. Using data on the incidence of cancer illness and 
death in the population, these willingness to pay figures 
imply that the marginal value of reducing the anticipated 
incidence of cancer mortality by one in the population 
is 73,000 yuan and an average value of 795,000 yuan, 
which are about six and 60 times average household 
annual income, respectively. The big difference between 
the marginal value and the average value of fatal risk 
reduction corresponds to a very low estimated elasticity 
of willingness to pay with respect to fatal risk reduction. 
This finding challenges the validity of previous studies 
of the value of a statistical life, which are mostly based 
on average willingness-to-pay values of mortality risk 
reduction.   
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 1. Introduction 
 
Economic analyses of development projects and policies often involve assigning monetary 
values to human lives, especially in the areas of public health, occupational safety, 
transportation, and environmental protection, where human lives can be significantly affected by 
a proposed project or policy change. As resources are finite, trade-offs between other resource 
uses and reducing risks to life are inevitable. In order to help make rational choices in these 
tradeoffs, a concept of value of a statistical life (VSL), as opposed to a specific person’s life, has 
been defined and extensively studied
2. VSL is an economic value which measures the break-even 
point at which society as a whole is willing to pay (WTP) in order to reduce the statistical risk of 
death. 
 
Extensive VSL studies have been conducted in the industrialized countries, however, few studies 
on VSL can be found in the developing world. Almost all of the previous studies indicate that the 
VSL estimation results are sensitive to the sectors studied, the estimation methods employed, the 
risk reduction levels as well as the demographic and economic characteristics of the studied 
population. It is therefore very important to directly estimate VSL for a country of concern.   
 
A significant number of earlier VSL estimates come from studies that measure compensating 
differentials for on-the-job risk exposures in labor markets. Since the 1990s, however, the 
contingent valuation (CV) method has been widely used to estimate the value of a statistical life. 
An individual’s WTP for a specified death risk reduction can be elicited with a plausible CV 
scenario and a VSL can be estimated by dividing the WTP by the change in death probability.  
The advantage of the CV method over the traditional market approach is that a CV study can be 
flexibly designed even when no similar markets exist. This nature of the CV approach is 
especially important for the developing country context, because a good competitive market can 
hardly be found and data on risk and compensation are rarely available in most of the developing 
countries. However, the challenges in using the CV method to estimate VSL are enormous. 
Beside the conventional challenges in using CV method: questionnaire design, statistical 
analysis, strategic responses and elicitation method choices, etc., a particular challenge comes 
from the empirical finding that individuals may have difficulties in understanding a numeric 
probability change. Our analyses also show that the VSLs obtained from the previous CV studies 
which estimated WTPs for a couple of numeric risk reductions are incompatible with the 
theoretically defined marginal WTPs. These findings lead to suspicion of the validity and 
reliability of most of the previous CV studies for VSL estimation.     
 
A contingent valuation study of health risk reduction was conducted in three provinces of China 
in 2000. A VSL can be calculated based upon the WTP information from that survey and the 
cancer morbidity and mortality data. In the CV survey, respondents are not asked to evaluate the 
abstract probability reduction as done in conventional risk valuation studies, which is usually a 
difficult task for the respondents to complete. Instead, they are asked whether or not they are 
willing to buy a cancer vaccine that is effective for one year. This CV scenario is easy to 
understand and is similar to a market transaction. WTP functions of risk reduction can be 
estimated with data of cancer morbidity and mortality, and a marginal value estimation of risk 
                                                 
2 A comprehensive literature review on VSL studies can be found  in Miller (1999), Viscusi and Aldy (2003) and 
Australian Safety and Compensation Council (2008). 3 
 
reduction can be produced, which is in sharp contrast to the average value estimation of risk 
reduction as done in a conventional contingent valuation study.  
 
This paper is organized as follows. In the next two sections, we briefly present a literature review 
on WTP for mortality reduction and VSL estimation. The relationship between WTP for 
mortality risk reduction and VSL is developed in Section 4.  In section 5, we present our 
contingent valuation survey. The econometric methods are illustrated in section 6, and the data 
and the estimation results are presented in section 7 and 8. VSL calculation and simulation are 
presented in section 9. We conclude the paper in section 10.  
 
 
2. VSL Estimation Methods 
 
VSL estimation methods can be categorized into two types.
3 The first type of methods measures 
the loss of direct income. One representative approach is the so-called human-capital method, 
which calculates the present value of future income forgone due to a premature death. These 
approaches however have two well recognized short-comings. First, they do not take into 
consideration the intangible impacts on individual and family well-being such as suffering and 
loss of leisure, therefore are often regarded as the lower bound of the social cost. Second, these 
approaches only focus on the active population but ignore the value of children and aged people.  
 
The second type of approach measures willingness to pay or accept changes in human mortality 
risk. The principle of this type of methods is to use people’s preferences as a basis for the 
measurement of increase (or reduction) in human well-being related to the reduction (or 
increase) of mortality risk (World Bank, 1998). As the “consumer surplus” from living can be 
many times higher than human capital, studies using the willingness-to-pay approach generally 
give a higher valuation of life than those using direct income losses. Using surveys in Taiwan 
and Los Angeles, Alberini and Krupnick (2000) found the WTP estimates gave values 1.61-2.66 
times higher than the loss of direct income.  
 
There are two ways of empirically estimating individuals’ WTP for mortality risk reduction: the 
revealed preference approach, which can use compensating wage or consumer behavior data, and 
the stated preference approach, such as the contingent valuation method (Krupnick et al., 2002). 
The revealed preference approach often uses differences in wage rate to measure compensations 
that people require for differences in risk of dying or falling ill caused by occupational hazards. 
Viscusi and Aldy (2003) provide a comprehensive survey of compensating wage studies in the 
US and other countries. The recommended VSL figures range from 4 to 9 million dollars for the 
US case and 0.8 to 74.1 million dollars for other countries. 
 
Besides the sensitivities of the estimation results to the studied sectors or markets, the VSL 
estimation with the revealed preference approach also suffers from some other serious 
limitations. First, in the labor market or durable goods consumption markets, inactive population, 
especially the elder people, cannot be included. Secondly, workers in the labor market may not 
be perfectly aware of the workplace risk. Thirdly, this approach also implicitly assumes that 
                                                 
3 A detailed introduction of the various approaches using the loss of direct income can be found in World Bank 
(1998). 4 
 
people have no preference for certain profession choice, which is not true in some of the cases. 
Finally, many labor market hedonic studies also suffer from measurement errors. Workers within 
an industry or occupation group are typically assigned with the same workplace fatality rates, but 
in reality, the fatality rates can be quite different for different people even working in a same 
industry.    
 
The contingent valuation (CV) method is a stated preference approach. It uses surveys to ask 
individuals to report directly their WTPs for a specified and hypothetical reduction of risk of 
premature death. An obvious advantage of the CV method over the hedonic price approach is 
that the former has more flexibility in choosing a population and a specific type of risk (Alberini 
and Chiabai, 2007). However, a well-behaved CV analysis is more demanding for technical 
expertise in questionnaire design, sample choice, treatment of responses, etc. The biggest critic 
of this method is that it is hypothetical, which requires a researcher using this method to 
undertake additional efforts to remind people of other related factors such as real budget 
constraints. 
 
3. VSL Estimation in Developing Countries 
 
Although numerous VSL studies have been conducted in the U.S. and other developed 
countries
4,   there are few studies directly conducted in the developing world. Three types of 
efforts have been made in order to obtain a VSL estimate in a developing country: scaling, meta-
analysis and direct estimation (Bowland and Beghin, 2001). The scaling approach adopts 
valuation estimates made in developed countries with calibrations based on income differences.  
However, the scaling approach is often problematic as per capita income level is not the sole 
determinant of VSL, because other factors such as regional economic and demographical 
characteristics and cultures can also affect VSL (Mead and Brajer, 2006). Besides, income 
elasticity is not constant. Chestnut et al. (1997) and Alberini and Krupnick (2000) indicated that 
in most of the cases, the VSL’s income elasticity is higher for poorer people than for the richer 
one. The survey made by Viscusi and Aldy (2003) of the studies conducted in the developed 
countries revealed an income elasticity of 0.5 to 0.6 , while Bowland and Beghin (1998) found 
an elasticity of 1.8 for the developing countries studied. 
 
The meta-analysis of VSL uses existing studies conducted in the industrialized countries to 
derive a VSL prediction function for developing countries, taking into considerations of 
differences in risk, income, human capital levels as well as demographics of a country. For 
example, Bowland and Beghin (2001) analyzed over 40 wage-risk studies conducted in the 
industrialized countries, and found VSL not only depends on income level but also on other 
factors such as average age, education level, coverage degree of social security system, and other 
social situation. Based on their estimation models and available data in Santiago, Chile, they 
predicted the cost of mortality due to air pollution for this South American city.  
 
However, even the meta-analysis approach is still problematic to developing countries. Some 
specific factors in a developing country, such as distorted wages, cross-subsidy of public 
services, difficulties in valuing various homemaking services, high unemployment rates, are 
obviously contradictory with some implicit assumptions made in the original studies such as the 
                                                 
4 A summary table of the study results is presented in the appendix. 5 
 
existence of a perfectly competitive labor market for a wage-risk hedonic study. In addition, 
these studies often have to ignore the potentially important roles played by age and health status 
in mortality risk reduction valuation (Krupnick et al. 2002; Arberini et al. 2004 and Hammitt and 
Liu, 2005). Given the fact that people living in different countries do not necessarily share the 
same demographical structures and health characteristics, the simple scaling principle or the 
independent-variable-based scaling principle do not permit us to include the differences existing 
in the original mortality risk between the countries. Chestnut et al. (1997), based on two 
paralleled CV studies in Bangkok and Los Angeles, revealed that the differences in the average 
increase in the incidence rate for certain respiratory diseases with the same percentage increase 
of pollution are incomparable between the two cities.  
 
Obviously if it is feasible, it is always preferable to conduct VSL studies directly for a country 
itself. A small number of contingent valuation studies have been designed and carried out in 
developing countries to estimate VSL. Alberini et al. (1997), Alberini and Krupnick (2000), 
Hammit and Graham (1999), Hammit and Liu (2004), and Bhattacharya et al (2007) are a few 
examples. Only until very recently a couple of contingent valuation studies have been conducted 
in China to estimate VSL. Wang and Mullahy (2006) conducted a CV study in Chongqing to 
estimate WTP for reducing the risk of fatality due to air pollution and the value of a Chinese 
statistical life.  Based on the face-to-face interviews of 550 individuals in 1998 with an open-end 
WTP question format backed by a bidding game in case of respondent’s hesitation, a probit 
estimation and bootstrap process gives an estimate of medial WTP for saving a statistical life to 
be 286,000 yuan, or 34,458 US dollars. Hammitt and Zhou (2006) estimated WTP values for 
three health endpoints: cold, chronic bronchitis and fatality, based on an in-person interview 
conducted in 1999. The survey was carried out in three locations: Beijing, Anqing and the rural 
areas near Anqing. WTP was elicited by a double-bounded, dichotomous-choice format. Each 
respondent was asked whether she/he would purchase a treatment which provides a stated risk 
reduction at a specified price. After the two dichotomous-choice questions, the respondents were 
asked to state their maximum WTP for the risk reduction in an open-ended follow-up. Their 
estimations gave a sample-average median value of a statistical life ranging between 33080 yuan 
to 140590 yuan ($4000 to $17,000). Both studies only concentrate their surveys in a 
geographically limited regions, therefore the conclusion cannot be simply extrapolated to other 
regions, given the great regional disparities between different provinces. Both surveys related 
their mortality reduction WTP questions directly to environmental quality improvements. 
Although the studies reminded respondents to only evaluate their mortality risk reduction 
contributed by environmental quality improvements, the respondents might not have totally 
excluded from their valuation other benefits caused by pollution reduction. The vast differences 
in the estimation results call for further investigations.  
 
4.   Contingent Valuation of a Statistical Life 
 
The linkage between a WTP for fatal risk reduction and VSL can be constructed from a life-
cycle consumption model with an uncertain lifetime (Yaari, 1965; Sherpard and Zeckhauser, 
1982; Cropper and Sussman, 1990). Following Alberini et al. (2004), the life-cycle model can be 
summarized below.  
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 ut(Ct) is the utility of consumption in each period t that this individual can receive. To get its 
present value, we can multiply it with the probability that the individual survives to that period 
qj,t and then discount it to the present at the subjective rate of time preference, ρ.
5  
 
In the life-cycle consumption model, Vj  is maximized subject to initial wealth, Wj, and a budget 
constraint that reflects opportunities for borrowing and lending. The two cases usually 
considered are the case of actuarially fair annuities and the more realistic situation in which the 
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Where y is income and C is consumption. We can use the life-cycle model to determine the 
amount of initial wealth that an individual would give up to reduce Dj, the probability that he dies 
during the current period. A reduction in Dj will increase the probability that the person survives 
to all future periods since, by definition, qj,t is the product of the probabilities that the individual 
does not die in all periods from j to t-1, 
 
qj,t = (1-Dj)(1-Dj+1) . . . . (1-Dt-1) .          ( 3 )  
 
The rate of substitution between Dj and Wj,  which keeps the expected utility Vj to be constant, 
corresponds to the value of a statistical life for a person of age j, VSLj, 
 
VSLj = (∂Vj/∂Dj)/( ∂Vj/∂Wj) = dWj/dDj .              ( 4 )  
 
dWj represents the amount an individual is willing to pay for the reduction in Dj. VSL is the 
marginal value of a risk change, as defined in equation (4).  
 
In contingent valuation studies on VSL, an individual is usually presented with a small risk 
reduction (∆D), and a WTP for this small risk reduction is elicited. Because the proposed risk 
reduction is small, the VSLj, as defined in equation (4), can be roughly equal to the average WTP 
of the risk reduction (Albrini et al, 2004); i.e.,   
 
VSLj = WTPj/∆Dj .                 ( 5 )  
 
                                                 
5 qj,t shows the mortality rates of the individual in the period from j till T. These mortality rates surely depend on the 
health situation of the individual at the beginning of the period j. Therefore, in certain sense, the qj,t should be 
personalized by the health status of each individual. 7 
 
However, the contingent valuation estimates of VSL, which are based on equation (5), can have 
significant biases from the theoretically correct estimates as defined in equation (4). First, the 
proposed risk reduction in a CV study cannot be too small in order to be sensible to the 
respondents. Therefore the approximation of equation (5) to equation (4) can be a question in 
reality. Secondly, it can be a difficult task for a respondent to calculate his/her WTP for a small 
risk reduction. A systematic error may exist in a WTP calculation with an individual.  
Previous empirical studies find that the VSL estimates as defined in equation (5) are sensitive to 
the scales of the risk reduction proposed in CV studies. WTP estimates are found not 
proportional to the level of risk reduction. Krupnick et al. (2002), Alberini et al. (2004) and 
Alberini and Chiabai (2006) studied the VSLs for USA, Canada and Italy with the CV approach 
for two different levels of mortality risk reduction, with one to be 5 times the other, but found 
that the WTP is not 5 times high, and therefore different VSL estimates can be produced for a 
same sample of population.
6  Similar findings are also reported in Muller and Reutzel (1984), 
Vassanadumrongdee and Matsuoka (2005), Hultkrantz et al (2006), and Corso et al. (2001), 
Andersson and Svensson (2008), Bhattacharya et al. (2007), where WTP increases less than 
proportionally with the size of risk reduction. Hammit and Graham (1999) provided a synthetic 
analysis for the 19 CV studies published before 1995 that have employed more than one level of 
risk reduction in the surveys, and found that, although many studies did find an increasing trend 
of WTP with risk reduction, none of the 19 studies shown the proportionality between WTP and 
the proposed risk reduction. Persson et al. (2001) elicited WTP information for risk reductions of 
10, 30, 50 or 99 percent of mortality risk for one year and provided a graphical relationship 
between WTP and absolute mortality risk reduction. They find that WTP is increasing with the 
level of risk reduction but the increasing rate is decreasing.  
 
No theoretical studies have been found on the relationship of WTP with risk reduction. While a  
theoretically-correct functional form of WTP with respect to risk reduction is believed to be 
dependent on the utility function and the wealth function as presented in equations (1) and (2) 
above,  one can project that it is an increasing function and to be concave when the risk reduction 
level is high enough due to the budget constraint.  
 
To overcome the shortcomings of contingent valuation studies in estimating VSL as discussed 
above, it is logical to require researchers to estimate functional forms of WTP with respect to 
risk reduction and to derive a marginal WTP estimate of risk reduction. This study represents 
such an effort, where marginal WTPs are estimated and simulated with different WTP functional 
forms, and the results are compared with the average WTPs of risk reduction.   
 
5.  The Health Survey  
 
In 2000, we conducted a household survey on public health and environment in three rural areas 
in China: Danyang (Jiangsu Province), Liupanshui (Guizhou Province) and Tianjin suburban. In-
person surveys, where respondents complete the questionnaires with close guidance from 
enumerators
7, are conducted. About a half of the sample is workers who were working in local 
                                                 
6 In Alberini et al. (2004), the mean WTPs for 1/10000 and 5/10000 risk reductions are $370 and $466  in Canada, 
and $487 and $ 770  in the United States.  
7 The major intention is to minimize the potential interviewer bias. The interviewers read another copy of identical 
questionnaire to the respondents, but can not directly work on the questionnaire, and the respondents do not need to 8 
 
township-village enterprises. One to three workers were randomly selected from each factory 
based on the worker name list and were invited for personal interviews. Another half of the 
sample is rural household heads, or farmers, who were interviewed in or around their houses. A 
list of communities was first randomly selected in the three municipalities, and a certain number 
of household interviews were assigned to each selected community. Teams of enumerators were 
sent to the communities, and the enumerators knocked the doors of the households selected and 
invited the heads of the households to participate in the interviews. If the heads of the households 
were not at home or refused to be interviewed, the neighbor households were then selected, until 
the total number of interviews in this community reached the target number.  
 
The questionnaire was developed from a similar questionnaire previously employed in China, 
and was pre-tested in each of the municipalities. Special cares were paid to the WTP section of 
the questionnaire.  Several group discussions and two pre-tests were conducted at each of the 
three study areas, focusing on the wording of the WTP questions as well as the price range. The 
survey was conducted by teams of researchers, professors and graduate students, and the survey 
teams were first trained by one of the authors of this paper, and then participated in the group 
discussions and the pre-tests of the questionnaire in order for them to fully understand the issue 
and to get familiar with the task before the formal surveys started. The final version of the 
questionnaire includes seven parts: personal characteristics, environmental perceptions and 
attitudes, local pollution control issues, pollution impacts on respondents and their families, 
household situation, health status, and finally the contingent valuation questions about cancer 
prevention. 
 
The willingness-to-pay question on health risk reduction is posed in the form of cancer risk 
prevention. Aiming to obtain detailed information about the attitudes of each respondent toward 
the proposed cancer vaccine, we use a Multiple Bounded Discrete Choice (MBDC) format to 
check about respondent’s WTP. This format combines two aspects of development from the 
traditional dichotomous choice (DC) WTP question. On one hand, it allows respondents to vote 
on a wide range of referendum thresholds, and on the other hand, a scale of “polychotomous 
choice” response options from “Definitely No” to “Definitely Yes” is also provided to allow 
respondents expressing their levels of voting certainty for the referendum at each price level. In 
this way, MBDC survey technique actually reinforces both quantity and quality of CV data
8.  
 
The WTP question in our questionnaire is as follows: 
“Suppose there is a medicine that can prevent you from getting cancer for one year with one 
dose. There would be no side effects. But after one year, the medicine will fully stop functioning. With 
given quality and impact, the price of the medicine could be different. We would like to know the 
possibility for you to buy such a vaccine, with different prices, to make sure you would not fall ill of 
cancer for one year.  
                                                                                                                                                             
speak out their answers to the interviewers. But just like with a mail survey, the final quality of the questionnaire 
completion can not be controlled by the enumerators.   
8 For more discussions, see Wang and He (forthcoming). 9 
 
Please note that, 1) different people have different probabilities to fall ill of cancer. Therefore, the 
likelihood that different people truly need the medicine is different. If a person will surely not get 
cancer in the next year, he may not need this preventive measure; and 2) with a given income, a person 
also needs to buy other goods and services such as food and clothes, and may spend money to prevent 
from other diseases.  
We only want to know the likelihood that you would buy such a medicine, given the following list of 
prices, to make sure you would not fall ill of cancer in the next year. There is no right or wrong 
answers; we only want to know how you would react to the different prices. Please select one 
possibility under each price given below.” 
 
Price  Definitely not  Probably not  Not sure  Probably yes  Definitely yes 
Free(0 yuan) 
)
       
10 yuan         
20 yuan         
40 yuan         
60 yuan         
90 yuan         
150 yuan         
200 yuan         
300 yuan         
500 yuan         
1000 yuan         
2000 yuan         
5000 yuan         
8000 yuan         
10000 yuan         
15000 yuan         
 
 
6.  WTP Estimation with MBDC Data 
MBDC format WTP data, offering rich information with extended bid price choices and multiple 
options of certainty levels, have been used in the past in a number of contingent valuation 
studies. Several of the studies employing the MBDC data, such as Alberini et al. (2003), 
implement an extension of the Random Valuation Model proposed by Wang (1997), which 
views the value that an individual attaches to any amenity (including market traded goods) as a 
random variable with an unspecified probability distribution (Shaikh et al. 2007). Following this 
logic, the data obtained from the MBDC format are several observations of an individual WTP 
distribution that is attached to the amenity in question. Wang and Whittington (2005) and Wang 
et al. (2004a) further proposed a CV approach called Stochastic Payment Card (SPC). This 
approach extends the MBDC format WTP question and directly elicits the numerical likelihood 
information of the respondents beside the verbal likelihood information. With this arrangement, 
we are able to directly estimate individual valuation distributions from the SPC data provided by 
the MBDC format questionnaire.  
 10 
 
In this paper, we will use an alternative analytical strategy initially proposed in Wang and He 
(forthcoming) to estimate individual valuation distributions for cancer risk reduction. This new 
approach is based on the random valuation theory as described in Wang (1997) and Wang and 
Whittington (2005) and uses a similar data encoding strategy as used by Evans et al (2003). 
Subjective verbal likelihood responses given by MBDC respondents are first encoded into 
numerical likelihood data, or SPC data. Then the SPC data are analyzed to estimate individual 
valuation distributions, as did in Wang and Whittington (2005).   
This new WTP estimation strategy suggests that an individual i may not know the exact value of 
his WTP for risk reduction but he does have some idea about the range of values in which it lies. 
When the proposed bid price comes out to be sufficiently lower (higher) than the value range, he 
will be relatively more sure about his positive (negative) answer, but when the bid price is 
located close or in the value range, he will be more unsure about his choice. So we can express 
an individual i’s WTP for risk reduction, represented by Vi, as a random variable with a 
cumulative distribution function F(t). The mean value of Vi is i, which represents the mean 
WTP of the individual i for the cancer preventive medicine, and the standard variance is i . So 
we can write the WTP model as,  
     V i=µi+i           ( 6 )  
where i is a random term with a mean of zero. When given a price tij for the cancer vaccine, the 
probability for the person to say “yes” will be, 
     P ij = Prob(Vi>tij) 
                              =1-F(tij)                ( 7 )  
Once Pij, the probabilities for individual i to agree on the price tij, is known to a researcher, either 
by assigning numerical values to the verbal MBDC data or by directly asking individuals of their 
numerical likelihood information as did with the SPC approach, equation (7) can be estimated 
for each individual.  The estimation model can be constructed as follows: 
     P ij = 1-F(tij) + λi            ( 8 )  
where the error term λi has a mean of 0 and a standard variance of 
2.  can be constant for a 
respondent i, but its value will be different for different respondents. Pij is a dependent variable, 
which is the certainty answer chosen from “definitely yes” to “definitely no” by a respondent i at 
price j. Pij will take values between 0 and 1, with the value approach to 1  meaning a higher 
certainty of accepting and the value approach to 0 meaning a lower certainty. These values can 
be viewed as a continuous variable. tij is an independent variable, which is the bid price proposed 
in the questionnaire. We can also consider tij as a continuous variable. 
Assume a specific functional form for Fi(•), such as of a normal distribution, with a mean i and 
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Assume λi also has a normal distribution. Then,  11 
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and the log likelihood function is: 







































1         (10) 
This is equivalent to a least square nonlinear estimation;  has no influence on the estimation, as 
long as it’s a normal distribution. With the log likelihood function (10), i and i can be directly 
estimated for each individual i with the MBDC data. 
Once i is estimated for each individual, models can be constructed and estimated to analyze its 
determinants. One simple example is to have the following linear functional form: 
i= 0 + xi' + e1       (11) 
where x are personal specific characteristics. s are coefficients to be estimated; e1 is a random 
errors. 
 
7.  Survey Data Analyses 
7.1  WTP Responses  
 
1,933 respondents accepted to be interviewed. 594 respondents did not give positive answers 
(i.e., a “not sure”, “probably not” or “definitely not” answer was selected) at the price of zero, 
which may reflect that the respondents do not think they would need this preventive medicine. At 
the other end, 205 persons did not give negative answers (i.e., definitely yes, probably yes or not 
sure was selected) even at the highest bid price, 15,000 Yuan, which means that the price range 
did not cover the whole WTP range if people answered the questions honestly.
 9 838 respondents 
have their WTP located in the price range. Two respondents have cancer so the preventive 
medicine is not meaningful to them. 135 respondents did not fully complete the questionnaires, 
and 146 respondents gave some unreasonable answers to the likelihood questions, such as giving 
a higher acceptance probability for a higher bid price
10. Those responses would have been 
corrected by the enumerators if it is a traditional in-person interview. Table 1 summarizes the 
statistics of the responses.   
 
7.2 Characteristics of the Respondents 
 
                                                 
9 Almost all members in the focus group and pre-tests believed 15,000 Yuan to be more than the highest possible 
WTP for a medicine preventing cancer for one year. But apparently, some people may have very high WTP for such 
a medicine if they give honest answers.   
10 This may make sense in reality if people believe that a higher price means a higher quality. 12 
 
Table 2 reports the descriptive statistics of the respondents in three categories: 1) 594 
respondents who give negative answers at the zero bid (no demand); 2) 205 respondents who are 
positive even at the highest bid (extremely high demand), and 3) 838 persons whose WTPs are 
covered by the bid range (normal demand). The sample statistics are given in the third column. 
The stars marked in the first three columns indicate the significant difference of the variable 
from the category 3, which will be used in the following econometric analysis.  
In Table 2 we can see that the observations in category 3 with normal demand share very similar 
statistical characteristics with the whole sample. The only variable that seems to have a 
significant difference is the income uncertainty in future 5 years.  When there are statistical 
differences between the subsamples, we generally believe these differences are logical: people 
who have answered negatively at the zero bid generally have lower income level, fewer cases of 
cancers observed in their families and relatives, lower degree of trust or need for such a 
medicine. People reporting positive answers at the highest bid, on contrary, have much higher 
income level, more frequent cases of cancers observed in their families and relatives, high degree 
of trust or need of such a medicine. These findings are further supported by the Probit analyses 
reported in Table 3, where the probability for a respondent to report a negative answer at zero bid 
and the probability for a respondent to report a positive answer even at the highest bid are 
modeled, with respect to the respondents in category 3 whose WTP is covered by the payment 
range. The statistically significant independent variables are family income (and the future 
income uncertainty for the case of negative answer at the zero bid), relatives diagnosed with 
cancer, and the two dimensions of perception measurements of people on the preventive 
medicine: trust and need. However, other socio-demographical variables, such as age, sex, 
profession, health habits and religion, etc., do not show significant differences. This implies that 
the survey respondents do base their WTP answers on their payment capacities, their real needs 
and trust in the medicine. 
  
7.3 WTP Response Statistics 
 
The frequencies and the percentages of WTP responses of the whole sample (including all of the 
three categories) are presented in Tables 4-1 and 4-2. Based on Table 4-2, inverted stochastic 
demand curves for the whole sample can be drawn. Tables 5-1 and 5-2 show the frequency 
distribution and the percentage distribution of responses of respondents with normal demands. 
As shown in Table 5-1, the percentage of “definitely yes” answer is decreasing fast from 70.29% 
at the price of zero to less than 0.2% at the price of 8000 yuan. While the percentage of 
“definitely no” answers increases steadily with the price offered, from 0% at price of zero to 
about 87.7% when the price increases to 15000 yuan. In total, over 37% of the responses are 
uncertainty responses (probably yes, not sure, probably not) which happen between the prices of 
90 and 1000 yuan. This indicates that the respondents have relatively important uncertainty in 
their WTPs. This, to certain degree, justifies the use of MBDC format and reveals the existence 
of individual WTP distribution. 
 
8.  WTP Estimation Results 
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8.1.  Individual WTP 
 
To estimate the mean WTP, i, for each of the 838 respondents whose WTP distribution is 
covered by the MBDC price range, we conduct maximum likelihood estimations with normal 
distribution functions as shown in equation (4). All redundant answers at the two ends of the 
payment card, i.e. those “definitely yes” answers at the prices below the highest price where a 
“definitely yes” answer is given and those “definitely no” answers at the prices above the lowest 
price where a “definitely no” answer is given, are deleted. After doing so, each respondent has 2 
to 11 answers getting into the maximum likelihood estimation.  
     
The benchmark encoding strategy for the verbal likelihood data is to use 0.999 for “definitely 
yes,” 0.75 for “probably yes,” 0.50 for “not sure,” 0.25 for “probably no,” and 0.001 for 
“definitely no”.
11 Wang and He (forthcoming) tried other encoding strategies and found the 
estimation results were relatively stable if a symmetrical encoding strategy was used. The same 
conclusion is drawn in Evans et al (2004). In the following discussions only the results based on 
the benchmark encoding strategy will be presented.   
 
The distributions of the estimated mean value of individual WTP (μi) are given in Table 6-1. The 
mean WTPs vary from 0.27 to 11,872.18 Yuan, with a sample mean of 759 yuan (or, 5.6% of 
sample average household annual income) and a medium value of 172 yuan.  
 
8.2.  Average WTP for Risk Reduction 
 
With the estimated individual WTPs and the expected cancer risk reduction for each individual, 
an average value of cancer risk reduction can be calculated for each individual, and a sample 
mean value can be obtained. This sample mean value corresponds to the VSL estimate in a 
conventional contingent valuation study for mortality risk reduction.  The morbidity-based 
average value of risk reduction is corresponding to a lower bound of VSL and the mortality-
based value corresponding to an upper bound. The reason is that the cancer morbidity risk is 
always higher than the cancer mortality rate: falling ill of cancer does not necessarily mean 
dying, but not falling ill of cancer means that the individual will not die of cancer. The 
morbidity-based average value is in fact the value of cancer, which should be lower than the 
value of life. The WTP divided by individual’s expected value of cancer mortality corresponds to 
an upper bound of VSL, as the WTP obtained in our survey does not only include the WTP for 
avoiding death caused by cancer but also include WTP for avoiding suffering and medical 
expenditures that may be caused by a cancer. 
 
The mean value of the morbidity-based average value of cancer risk reduction is estimated to be 
0.89 million yuan, while the median is 0.18 million yuan, for the group of respondents with a 
normal demand of cancer vaccine. The mean value of the mortality-based average value of 
cancer risk reduction is 1.97 million yuan and the median value is 0.39 million yuan
12. The 
                                                 
11 The values of 1 and 0 cannot be used for the answers of “definitively yes” and “definitely no” because a normal 
distribution function is assumed.  
12 The results here are only for those respondents with a normal demand of cancer vaccine whose WTP is covered 
by the payment card. Those who do not need a vaccine as described in the survey cannot be included in the analyses. 
This is a shortcoming of such a study, which is similar to the hedonic wage studies that cannot include those people 14 
 
distributions of the average value of risk reduction by age and sex are presented in Tables 6-2 
and 6-3. In general, a female values more than a male. A younger person values more than an 
older person.  
 
8.3.  WTP Determinants 
 
The estimated WTP means, i, can be further analyzed with a simple robust OLS regression on 
log WTP, as shown in equation (11), in order to see how the demographical, economical, social 
and health characteristics of a person can affect his/her WTP. The estimation results are reported 
in Table 7.  The regression gives consistent results for almost all of the variables. People having 
higher family income, with better education, having relatives diagnosed with cancer, having less 
future income uncertainty, having regular health check-ups, have relatively higher WTPs. The 
WTP is also positively associated with the degree of trust and subjective judgment on the need of 
the medicine. The income elasticity of WTP is found to be around 0.42, which is slightly lower 
than the estimate provided by Viscusi and Aldy (2003) which is about 0.5 and 0.6 for U.S. 
studies. Table 7 also gives the detailed coefficients and their significances for the age-, sex- and 
region-related variables. We do not find significant coefficients for the continuous age variable, 
which may be due to the fact that the correlation between age and WTP is not a simple linear 
one. But we do observe dummies of some age-ranges having interesting, significant coefficients. 
In Jiangsu, younger people are willing to pay more, and males are willing to pay more than 
females. The opposite is found in Tianjin and Guizhou, where old females are willing to pay 
more than old males and younger people. In general, males in Jiangsu are willing to pay more; 
old males in Jiangsu and old females in Tianjin and Guizhou are willing to pay the most, and old 
males in Tianjin and old females in Jiangsu are willing to pay the least.   
 
8.4.  Sample Selection 
 
The empirical results of the WTP model presented in Table 7 can be used to project an average 
WTP of the whole sample by substituting the values of the independent variables of all 
respondents into the model. The average WTP is estimated to be 439 yuan with a standard 
deviation of 546 yuan.  The average risk of cancer is 15.5/10000, and the morbidity-based 
average value of cancer risk reduction is about 283,000 Yuan. The average cancer mortality rate 
is 9.32/10000, and the mortality-based average cancer risk reduction is about 471,000 yuan. 
These estimates are lower than the estimates presented in section 8.1. One reason is that the WTP 
model used is in log term and therefore the average WTP projected by the model is compatible 
with the geometrical mean, rather than the algebra mean. When the WTP is in log terms, those 
large values in WTP play less influence in the mean estimation. When a linear WTP model is 
used, the estimates are compatible with the results for an average person presented in last 
section. This indicates again that the final outcomes are very sensitive to the choices of models if 
WTP models are used to project the final estimates.   
 
                                                                                                                                                             
who are not involved in the labor market studied.  Those respondents with extremely high demands of the vaccine, 
whose WTP values should be higher than 15,000 yuan, are not included in the estimation either. So the estimates 
obtained here are conservative ones.  
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While the log WTP models can significantly under estimate the final values, they can be 
employed to assess the potential biases that may be caused by excluding those outliers in our 
sample. The average WTPs can be projected for the groups of people with no demand as well as 
extremely high demand by the empirical WTP model. The results are summarized in Table 8. 
Higher VSL estimates are obtained when those people with extremely high demands are 
included, just as expected. When the empirical WTP model, which is estimated with the sample 
with a normal demand, is applied to the whole sample, the VSL estimates are slightly lower than 
but very close to the ones obtained with the normal sample.   
 
 
9.  Marginal Value of Risk Reduction 
 
In our study, WTP functions of risk reduction can be constructed and estimated, because the 
level of risk reduction for each respondent is different. As discussed before, the risk reduction in 
our study is the cancer morbidity and mortality rate that each individual is facing. The estimated 
WTP function of risk reduction can be used to simulate the marginal value of risk reduction, as 
shown in equation (4), which is a theoretically correct valuation. The estimated WTP function of 
risk reduction can also be used to simulate the average value of risk reduction, as defined in 
equation (5), which is an approximate value given by a conventional contingent valuation study. 
The results can be compared. 
 
The estimated relationships between WTP and risk reduction are presented in Table 9-1 for 
cancer morbidity rate and in Table 9-2 for cancel mortality rate. The cancer morbidity data are 
region-, sex- and age- specific, but the cancer mortality data are available only at the national 
level
13. The individual cancer morbidity rate and mortality rate are found to be significant 
determinants of their WTP for the risk prevention. This implies that our respondents do have a 
reasonable judgment of relative cancer risk and do base their WTP answers on the risk judgment.  
 
The results of six modeling strategies are presented in Tables 9-1 and 9-2. In model 1, the WTP 
is forced to be proportional to the risk reduction; i.e., WTP=a*RR, where RR is risk reduction 
and a is the coefficient which is individual specific. In theory, when risk reduction is very small, 
this should be the case. The marginal value and the average value of risk reduction with model 1 
are the same, and the estimation result are 226,700 yuan for morbidity risk and 282,843 yuan for 
mortality risk for an average person, who takes the sample average values for all related 
variables in the model except WTP and RR.  
 
In model 2, the WTP model is specified as WTP = a*RR + b*RR^2. The log likelihood test 
shows that model 2 is a significant improvement over model 1. Income turns out to be a 
significant variable. For an average person, the marginal value of cancer is 353,138 yuan and the 
average value of cancer is 433,119 yuan. For mortality risk reduction, the marginal value is 
810,879 yuan and the average value is 572,023 yuan. 
 
In model 3, it is assumed that individuals may have errors in judging their WTPs, and this error 
is determined by individual characteristics. The model is specified as WTP = a*RR + c. 
                                                 
13 The national-level cancer morbidity data are used for the respondents in Guizhou as the data for Guizhou are not 
available.  16 
 
According to the log likelihood values, model 3 is a significant improvement over model 1, 
however, the marginal value estimate is much lower with model 3 and even negative for 
mortality risk.  
 
In model 4, individual errors in both risk reduction judgment and WTP calculation are 
considered. The model is specified as WTP= a*RR + b*RR^2 + c. The results are much better 
according to the log likelihood values. The significant variables include the risk reduction, the 
square of the risk reduction and the personal characteristics. For an average person, the marginal 
value of cancer is estimated to be 68,410 yuan and the average value of cancer is estimated to be 
514,386 yuan. For mortality risk reduction, the marginal value is 72,616 yuan and the average 
value is 794,692 yuan.  
 
Model 5 tests the overall significance of including the interactions of risk reduction with personal 
characteristics, and it is found that the interaction is not significant. 
 
Model 6 gives another version of model 5, but the dependent variable in model 6 is log WTP; 
i.e., log(WTP) =a*RR + b*RR^2 + c. The interactions of risk level with personal characteristics 
are also tested, which did not show a significant improvement. The marginal value and the 
average value of cancer are estimated to be 29,208 yuan and 110,801 yuan for an average person 
respectively. The marginal value and average value of mortality risk reduction are 25,787 yuan 
and 183,385 yuan respectively. Because the dependent variable is in log term, the values 
estimated are corresponding to the medial value of the WTP in the sample.  
 
In general, the results presented in Tables 9-1 and 9-2 are consistent, but the model performance 
presented in Table 9-2 is lower than that presented in Table 9-1. It is understandable because the 
results presented in Table 9-2 are for mortality risk reduction which is only based on a national-
level dataset that has no variation between regions. 
 
Model 4 and 6 are the best among the alternative models. Model 4 in Table 9-1 gives a value of 
cancer of 68,410 yuan with the marginal value approach and 514,386 yuan with the average 
value approach. Model 4 in Table 9-2 gives a VSL of 72,616 yuan with the marginal value 
approach and 794,692 yuan with the average value approach. One can see a tremendous 
difference between the results obtained from the marginal value approach and the average value 
approach.   
  
Our results are in contrast to those results previously obtained in China. Wang and Mullahy 
(2006) provided an estimate of medial WTP for saving a statistical life to be 286,000 yuan in 
1998, and Hammitt and Zhou (2006) provided a sample-average medial value of a statistical life 
ranging between 33,080 yuan to 140,590 yuan in 1999. Our results are for the year of 2000. The 
medial value of statistical life is estimated to be 395,694 yuan with the simple average approach 
and 183,385 yuan with the log WTP model. With the marginal value approach, the VSL is 
estimated to be 72,616 yuan for an average person. With the average value approach, the VSL is 
estimated to be 794,692 yuan for an average person based on the WTP modeling result and1.97 
million yuan based on a simple sample average. 
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In order to see how the estimation result changes with the level of risk reduction, we conduct 
simulations based on the modeling results of models 4 and 6. Presented in Table 10 are the 
simulation results of cancer morbidity risk reduction
14. Individual characteristics are fixed at 
their sample average values. The simulations show that the average values of risk reduction are 
always higher than the marginal values. At the risk reduction level of 1/1000, the WTP model 
gives an average value of 11.4 times the marginal value, and the log WTP model gives an 
average value of 5.3 times the marginal value. The marginal values do not change much when 
the risk reduction is small. However, the average value is decreasing dramatically along with the 
increase in risk reduction.  This is consistent with the empirical findings that higher VSL 




10. Discussion and Conclusion 
 
In this paper, we present a study on the value of statistical life (VSL) in China which uses data 
on cancer morbidity and mortality observed in China and information on willingness-to-pay 
(WTP) for cancer risk prevention that was collected in a contingent valuation study conducted in 
three areas of China in 2000.  The cancer risk information is age, sex and region specific, which 
can be mapped with the respondents’ characteristics to produce an estimate of cancer risk for 
each of the respondents. WTP for cancer risk reduction is elicited with a hypothetical cancer 
vaccine that can prevent a person from getting cancer for one year.  
 
With the conventional CV approach, the mean value of individual VSLs based on the cancer 
mortality data is estimated to be 1.97 million yuan, or 150 times of average household annual 
income, which is 13230 yuan for our sample. Because the WTP in the study is more than for 
avoiding death, the value can overestimate the VSL. This estimation can also be significantly 
affected by a small group of individuals who value lives extremely high. This mean value is 
reduced to about 800,000 yuan, or 60 times of the average household annual income, when it is 
calculated by the sample mean WTP divided by the sample mean cancer mortality reduction 
(759*10000/9.5). This is equivalent to the total WTP divided by the total lives saved, which is 
more relevant to policy analyses. However, the former approach is more compatible with the 
VSL definition, which is based on an individual’s WTP for risk reduction. 
 
VSL can also be projected with the empirically estimated WTP models by substituting the mean 
values of the characteristic variables into the models. The average value approach gives a VSL 
estimate of 795,000 yuan, or 60 times of the average household annual income
15. The marginal 
value approach gives a VSL of 73,000 yuan, which is about 10 times lower than the estimate 
obtained with the average value approach.  As the marginal value approach is a theoretically 
correct approach, this sharp difference provides a strong challenge to the validity of the average 
value approach, which has been used widely in previous contingent valuation studies of VSL. 
Also note that the WTP function of risk reduction in this study is estimated with cross-individual 
data which is based on the variations in WTP and level of risk reduction between individuals. It 
                                                 
14 As discussed before, the modeling results with cancer mortality are poorer than those with cancer mortality. But 
the simulation conclusion is the same for both the mortality model and the morbidity model. 
15 See table 9-2, model 4. 18 
 
is not clear how the function will change if variations in WTP and risk reduction level for a same 
individual are also included in the empirical estimation. 
 
While the projected mean WTP should not be statistically significantly different from the sample 
mean value if WTP is used as dependent variable, other types of models may produce 
significantly different results. In this study, a log WTP model is estimated and used to project the 
individual WTP values, and the projected mean WTP as well as the projected VSL are 
significantly lower than the values directly estimated from the sample. With a log WTP model, a 
VSL of 26,000 yuan is obtained with the marginal value approach and a VSL of 183,000 yuan is 
obtained with the average value approach
16. These results challenge the validity of the benefit 
transfer approach which intends to transfer the (modeling) results of a study site to a policy site, 
because the choice of models can significantly affect the final estimations. 
  
The estimates provided above are only from the part of sample where people have a normal 
demand of cancer vaccine. The WTP responses collected with the Multiple-Bounded 
Dichotomous Choice (MBDC) format do offer a significant amount of outliers which cannot be 
reasonably modeled. Those people with extremely high demands and those people with no 
demand of the vaccine are excluded in the final estimates. However, further analyses show that 
those outliers are reasonable responses. Those outliers can significantly affect the final 
estimation results, and may not be able to avoid in a future study of such type, especially for 
those people with no demand in cancer vaccine. This shortcoming is similar to the hedonic wage 
approach, which does not work for those who does not present in the studied labor market. 
However, the potential biases caused by excluding the two types of people from the final 
estimation may not be that serious in this particular study, as the WTP projection with the whole 
sample does not give a sensible difference from the part of sample with normal demands of the 
proposed cancer vaccine.  
 
The survey was conducted in the year of 2000, and the VSL should have changed significantly as 
the income of Chinese families has significantly changed. The WTP models estimated in this 
study can be used to adjust the estimates. The survey was conducted in three areas of China 
which have a wide range of economic and geographical coverage. However, the sample area 
only covers rural areas and small towns; big cities are not included. If one believes that people in 
the urban areas of China value reducing risks to human lives higher, the estimates presented 
above would be biased downward.  Therefore, the estimates presented in this paper may be 
conservative. 
 
One unique design feature of this risk valuation study is that people are asked to value a cancer 
vaccine, rather than to value a specific number of risk change, which is found to be difficult to 
understand by the respondents, as used in a conventional risk valuation study. Our approach, 
while being more realistic and plausible to the respondents as it offers a reasonable market 
choice, runs risk that the respondents might not know what the cancer risk reductions are and 
therefore their WTP might not be sensitive to the cancer risk reduction they are facing. However, 
the modeling results on WTP and the estimated cancer risk show that this has not been a problem 
in this study; people’s WTP are significantly correlated with their expected cancer risk reduction.  
 
                                                 
16 See table 9-2, model 6. 19 
 
The results of this study reveal that a person who is richer, better educated, doing regular health 
checks, facing lower future income uncertainty, having relatives diagnosed with cancer, having a 
higher degree of trust in medicine, or feeling a higher degree of need for the medicine, has a 
higher WTP in general. VSL estimates are higher for women than men and are higher for 
younger people. They are also different for different regions in China.   
 
Even though this study can help to provide a better understanding of WTP for risk reduction and 
VSL, as one can see from the analyses above, this study cannot give a conclusive result for VSL 
that can be used for policy analyses in China. This study also challenged the validity of some of 
the previous CV studies on VSL, such as Wang and Mullahy (2006) and Hammitt and Zhou 
(2006). A more systematic research on VSL is warranted. 
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Table 1. Statistics of Survey Responses 
 
Category Definition  Number  of  respondents 
1  Normal Demand: WTP value covered by 
the bid price range from 0 to 15000 
Yuan 
838 
2  No Demand - don’t need the medicine 
even at price of zero 
594 
3  Extremely High Demand - need the 
medicine even at the highest price of 
15000 Yuan 
205 
4  With missing values or disordered 
answers 
281 
5 Age<16  2 
6 Cancer  patients  13 
7  Total number of respondents  1933 
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Mean Obs  Std. 
Dev. 
Min Max 
Social and demographical 
characteristics 
            
Worker (1=worker; 
0=otherwise)  0.499* 0.463***  0.607*  0.533  838 0.499  0  1 
Male (1=male; 
0=otherwise)   0.706 0.746** 0.7679* 0.699  838  0.459  0  1 
Age (years)  36.820  38.695***  35.000*  36.323  838  10.746  16  77 
Education (1=Secondary 
school or higher; 
0=otherwise) 
0.938 0.912* 0.976*  0.931 838  0.254  0  1 
Married 
(1=married;0=otherwise)  0.840 0.887***  0.762*  0.827  838 0.379  0  1 
Religion (1=yes; 0=no)  0.091  0.101*  0.095  0.080  838  0.271  0  1 
Economic  characteristics              
Income (household  
income last year, yuan)  13230 12614** 24411** 13397  838 8495  600  70000 
      Yuncertain (1=not sure 
about future income; 
0=otherwise) 
0.160** 0.195***  0.071*  0.134  838 0.340  0  1 
Physical and health 
characteristics              
Rcancer  (1=relative 
diagnosed with cancer; 
0=otherwise) 
0.095  0.071  0.202*** 0.088  838  0.284  0  1 
Smoking 
(1=yes;0=otherwise)  0.421 0.465*  0.405  0.421 838  0.494  0  1 
Healthcheck (1=Regular 
check-up; 0=otherwise)  0.382 0.359 0.417  0.374  838  0.484  0 1 
Perceptions about the 
preventive medicine              
Need (1=do not need the 
medicine at all, 
2=somewhat, 3=need) 
1.814 1.606***  1.952*  1.856  829 0.766  1  3 
Length (1=expected 
length of the preventive 
effect  1=less than 1 
year;  2=1year; 3=longer 
than  1 year) 
1.574 1.594*  1.829***  1.539 831  0.652  1  3 
Trust (1=not at all trust 
in the medicine; 
2=somewhat. 3= totally 
trust) 
2.067* 1.922*** 2.250***  2.104  836 0.527  1  3 
Regional  dummies              
Guizhou   0.310**  0.290***  0.254***  0.353  838  0.478  0  1 
Tianjin 0.352**  0.273**  0.327  0.309  838  0.462  0  1 
Note: The stars are to indicate the statistical significance of the differences from respondents in 
category 7,  based on the student T test.. *** represents a significance for 1%; ** for  5%; * for 10%.  25 
 
Table 3. Determinants of Extreme Demands for the Medicine 
 
Equation for No Demand  
(Probit: 1=no demand even at 
price of zero; 0= normal 
demand) 
Equation for Extremely High 
Demand 
(Probit Model: 1=yes at the 








































Tianjin  1.353 -0.714 
  (6.54)*** (2.43)** 
Guizhou  1.370 -1.713 
  (6.50)*** (3.79)*** 
Constant  0.394 -20.948 
  (0.37) (7.01)*** 
Observations  1380 913 
Absolute value of z statistics in parentheses.* significant at 10%, ** significant at 5%; *** significant at 1% 
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Table 4-1. Statistics of WTP Responses: Frequencies of the Whole Sample 
 
Price  Definitely 
not 
Probably 
not  Not sure  Probably 
yes 
Definitely 
yes  Total 
0 427  78 89 303 740  1,637
10 480  91 94 379 593  1,637
20 518  93 105 357 564  1,637
40 545 100 133 353 506  1,637
60 582 118 149 347 441  1,637
90 618 140 162 329 388  1,637
150 682 169 196 275 315  1,637
200 732 188 203 231 283  1,637
300 786 205 199 192 255  1,637
500 852 216 183 173 213  1,637
1000 981 196 163 136 161  1,637
2000 1,059  197 155 111 115 1,637
5000 1,13  196 141 88 82  1,637
8000 1,183  185 122 77 70 1,637
10000 1,232  161 120 59 65 1,637
15000 1,248  151 115 59 64 1,637
Total 13,055  2,484 2,329 3,469 4,855  26,192
 
 











0 26.084  4.765 5.437 18.509 45.205  100 
10 29.322  5.559 5.742 23.152 36.225  100 
20 31.643  5.681 6.414 21.808 34.453  100 
40 33.293  6.109 8.125 21.564 30.910  100 
60 35.553  7.208 9.102 21.197 26.940  100 
90 37.752  8.552 9.896 20.098 23.702  100 
150 41.662 10.324 11.973 16.799 19.243  100 
200 44.716 11.484 12.401 14.111 17.288  100 
300 48.015 12.523 12.156 11.729 15.577  100 
500 52.046 13.195 11.179 10.568 13.012  100 
1000 59.927 11.973 9.957 8.308 9.835  100 
2000 64.692 12.034 9.469 6.781 7.025  100 
5000 6.903  11.973 8.613 5.376 5.009  100 
8000 72.266 11.301 7.453 4.704 4.276  100 
10000 75.260  9.835 7.330 3.604 3.971  100 
15000 76.237  9.224 7.025 3.604 3.910  100 





















0 0 0 0 249 589  838 
10 41 11 14 320 452  838 
20 71 15 29 297 426  838 
40 92 27 56 291 372  838 
60 120  49 76 278 315 838 
90 153  70 89 262 264 838 
150 205 100 127 213 193 838 
200 251 121 133 170 163 838 
300 297 142 128 135 136 838 
500 358 158 110 113 99 838 
1000 477 145 84 71 61 838 
2000 553 145 71 43 26 838 
5000 621 145 46 19 7 838 
8000 672 136 19 9 2 838 
1 0 0 0 0  7 2 0  1 1 3410  8 3 8  
1 5 0 0 0  7 3 5  1 0 3000  8 3 8  
Total 5366 1480 986 2471 3105  13408 
 











0 0.000 0.000 0.000 29.714 70.286  100 
10 4.893 1.313 1.671 38.186 53.938  100 
20 8.473 1.790 3.461 35.442 50.835  100 
40 10.979  3.222 6.683 34.726 44.391  100 
60 14.320  5.847 9.069 33.174 37.589  100 
90 18.258  8.353 10.621 31.265 31.504  100 
150 24.463 11.933 15.155 25.418 23.031  100 
200 29.952 14.439 15.871 20.286 19.451  100 
300 35.442 16.945 15.274 16.110 16.229  100 
500 42.721 18.854 13.126 13.484 11.814  100 
1000 56.921 17.303 10.024 8.473 7.279  100 
2000 65.990 17.303 8.473 5.131 3.103  100 
5000 74.105 17.303 5.489 2.267 0.835  100 
8000 80.191 16.229 2.267 1.074 0.239  100 
10000 85.919 13.484 0.477 0.119 0.000  100 
15000 87.709 12.291 0.000 0.000 0.000  100 





Table 6-1. Distribution of the Estimated WTP with Normal Demand 
 
Variable Obs  Percentile Centile  [95%  Conf.  Interval] 
Wtp 835  0  0.269  0.269  0.269 
   10  11.326  6.776  15.400 
   20  39.322  31.794  46.897 
   30  69.673  60.000  84.881 
   40  120.869  97.512  130.716 
Mean :  758.8494  50  171.544  150.103  200.253 
Stand. Err.  1586.139  60  255.959  221.416  312.481 
   70  468.126  398.388  549.162 
   80  879.748  746.574  1147.648 
   90  2108.107  1793.560  2488.585 
   100  11872.180  11872.180  11872.18 
   
Table  6-2. Average Value of Risk Reduction by Sex  
  
Variable Sex  Obs  Mean  Std.  Dev.  Min  Max 
Morbidity Male  576 856,576.3  2168075 131.2368  2.20e+07 
 Female  249 954,089.4  1865910  438.253  1.42e+07 
Mortality Male  576 1,725,847  4212262 203.2255 3.45e+07 
 Female  249 2,519,660  4948185  753.1705  3.70e+07 
 
 
Table  6-3. Average Value of Risk Reduction by Age 
 
Variable Sex  age  Obs Mean  Std.  Dev.  Min  Max 
Morbidity Male  15-44  415 1,131,665  2495159  517.131  2.20e+07 
   45-54  116 179,377  325070.7  217.702  2287034 
   55-64  36 71,487  102289  131.2368  388329.4 
    65-74  8 45,707  60048.31 216.3856 147747.7 
   75+ 1 180  .  180.0348  180.0348 
 Female  15-44  213 1,062,087  1984652  1633.342  1.42e+07 
   45-54  30 326,019  609848.5  438.253  2803215 
    55-64  5 278,312  319122.8 37641.95 662462.8 
   65-74  1 171,591  .  171591.3  171591.3 
    75+ 0 . . . . 
Mortality Male  15-44  415 2,302,021 4831718 825.3475 3.45e+07 
   45-54  116 298,932  605489.8  414.5512  4355004 
    55-64  36 99,493  146848.8 203.2255 601343.5 
   65-74  8 61,381  78463.8  336.9885  194385.4 
   75+ 1 247  .  247.2682  247.2682 
 Female  15-44  213 2,854,431  5264090  4593.689  3.70e+07 
    45-54  30 545,312  1031117 753.1705 4817534 
   55-64  5 531,069  620468  59732  1260051 
   65-74  1 386,661  .  386661.3  386661.3 





Table 7.  Determinants of WTP with Normal Demand  
























Region-, age- and sex- 
specific dummies  Tianjin 
Guizhou 
Jiangsu 
age15_44_male -0.007  Reference  0.886 
 (0.03)  --  (3.98)** 
age45_55_male 0.464  -0.087  0.686 
 (1.71)  (0.18)  (2.39)** 
age55_65_male -0.294  0.123  0.045 
 (0.54)  (0.14)  (0.07) 
age65plus_male -1.774  No  Obs.  1.830 
 (2.10)**  --  (2.06)** 
age15_44_female -0.205  0.119  0.158 
 (0.77)  (0.47)  (0.42) 
age45_55_female 0.085  No  Obs.  0.264 
 (0.17)  --  (0.32) 
age55plus_female 1.578  2.296  -0.666 




















Projected  (Yuan) 
439.4 546.0  460.2  411.7 
Mean cancer 
morbidity  (1/10000) 
15.5 14.3  15.3  15.7 
Mean cancer 
mortality  (1/10000) 
9.3 8.2  9.1  9.5 
Average Value of 
morbidity (Yuan) 
283,273 382,548  301,424  261,446 
Average value of 
mortality (Yuan) 
471,442 664,767  505,530  431,596 
 















Model 6  
Log(WTP) 
Risk Reduction  1.705  19.808  13.939  74.795  5.990  0.023 
 (0.18)  (0.90)  (1.18)  (2.21)**  (0.99)  (3.17)*** 
Risk Reduction
2   -0.328    -0.782  -0.065  -0.0002 
   (1.06)    (2.00)**  (1.47)  (3.18)*** 
risk_worker 1.319  -5.571  -0.186  -6.850     
 (0.23)  (0.53)  (0.03)  (0.43)     
risk_smoking -3.868  -11.533  -4.281  -15.086     
 (0.69)  (1.31)  (0.69)  (1.10)     
risk_fincome -0.000  -0.001  -0.000  -0.001     
 (1.12)  (2.34)**  (0.60)  (1.02)     
risk_education 12.669 14.230  -4.153  -36.287     
 (2.11)**  (0.79)  (0.61)  (1.50)     
risk_Rcancer 8.794  19.533  -10.375  -28.900     
 (0.97)  (1.05)  (0.90)  (0.91)     
risk_uncertainty -3.638  -8.494  4.346  18.219     
 (0.39)  (0.60)  (0.42)  (0.72)     
risk_health check  -9.162  -7.938  -4.964  2.853     
 (1.80)*  (0.86)  (0.91)  (0.20)     
risk_religion 21.435  17.468  20.942  24.437     
 (1.54) (0.70)  (1.26)  (0.63)    
risk_trust 7.553  20.635  -2.006  -6.548     
 (1.85)*  (2.52)**  (0.42)  (0.48)     
risk2_worker    -0.061   0.031    
    (0.36)   (0.16)    
risk2_smoking    0.057   0.096    
    (0.52)   (0.71)    
risk2_fincome    0.000   0.000    
    (2.41)**  (1.00)    
risk2_education    -0.185   0.336    
    (0.83)   (1.32)    
risk2_Rcancer    -0.230   0.358    
    (1.09)   (1.21)    
risk2_uncertainty    0.221   -0.250    
    (1.05)   (0.82)    
risk2_health  check   0.088   -0.078    
    (0.65)   (0.45)    31 
 
risk2_religion    0.104   0.140    
    (0.46)   (0.47)    
risk2_trust    -0.147   0.103    
    (1.66)*   (0.78)    
Worker      -227.556 -160.414 -230.357  -0.049 
     (1.65)*  (0.91)  (2.07)**  (0.35) 
Smoking     178.560  254.001  80.636  -0.046 
      (1.20) (1.35) (0.69)  (0.32) 
Fincome      0.008 0.012 0.005  0.304 
      (1.06) (1.25) (0.85) (2.91)*** 
Education      312.897 761.388 149.948  0.652 
      (1.36) (2.94)*** (0.70)  (2.37)** 
Rcancer      679.293 781.307 498.976  0.565 
      (1.95)* (1.68)* (1.87)*  (2.30)** 
Uncertainty      -198.846 -268.940 -156.097  -0.444 
      (1.27) (1.20) (1.27)  (1.98)** 
Health check      -1.315  -70.683  -70.971  0.234 
      (0.01) (0.40) (0.65)  (1.68)* 
Religion     -263.355  -334.927  62.958  0.071 
      (1.14) (0.92) (0.28)  (0.28) 
Trust      430.417 454.759 401.105  0.414 
     (2.77)***  (2.24)**  (3.37)***  (2.93)*** 
Constant      -518.225 -1,144.424 -252.289  0.504 
     (1.28)  (2.32)**  (0.85)  (0.51) 
Observations  833  833  833 833 833  833 
Log-likelihood  -7363.41  -7340.67  -7300.07 -7296.83 -7304.22  -1745.13 
R-squared  -0.12  -0.07  0.03 0.02 0.03  0.05 
Typical person’s WTP-risk coefficient   
Constant  0  0  747.02 678.45 706.77  4.853 
Level term  22.67  51.31  1.677  10.192  5.990  0.023 
Squared term  0  -0.506  0  -0.106  -0.065  -0.0002 
Marginal WTP 
(Yuan)  226,700  353,138  16,770 68,410 39,351  29,208 
Average WTP  
(Yuan)  226,700  433,119  489,371 514,386 496,763  110,801 




Table 9-2: WTP Function of Cancer Mortality Risk Reduction 
  
Model 











Model 6  
Log(WTP) 
Risk Reduction  0.777  -0.886  7.579  32.562  2.481  0.020 
  (0.07)  (0.03)  (0.59) (0.92) (0.33)  (1.84)* 
Risk Reduction
2   -0.247    -0.321  -0.088  -0.0003 
   (1.86)*    (0.59)  (1.08)  (2.02)** 
risk_worker 4.511  -3.758  3.014  -0.776     
 (0.62)  (0.19)  (0.45)  (0.03)     
risk_smoking -4.592  -13.559  -9.048  -21.485     
 (0.69)  (0.90)  (1.43)  (1.15)     
risk_fincome -0.000  -0.002  -0.000  -0.001    
  (1.59)  (2.45)** (0.99) (0.84)     
risk_education 16.603  46.923  -5.069  -23.982     
 (2.06)**  (1.77)*  (0.62)  (0.76)     
risk_Rcancer 11.219  49.315  -10.449  -1.980    
 (0.95)  (1.45)  (0.92)  (0.05)     
risk_uncertainty -6.441  -21.249  9.326  42.298     
 (0.56)  (0.63)  (0.95)  (0.93)     32 
 
risk_health check  -11.627  -28.990  -2.674  -10.501     
  (1.85)*  (2.03)** (0.45) (0.58)     
risk_religion 28.130  66.962  26.888  87.209    
 (1.53)  (1.34)  (1.54)  (1.43)     
risk_trust 10.119  36.900  0.313  6.796     
 (2.02)**  (2.90)***  (0.06)  (0.41)     
risk2_worker    -0.126   0.014    
    (0.31)   (0.03)    
risk2_smoking    0.061   0.155    
    (0.21)   (0.52)    
risk2_fincome    0.000   0.000    
    (2.63)***   (0.43)    
risk2_education    -1.163   0.084    
    (2.51)**  (0.17)    
risk2_Rcancer    -1.084   -0.079    
    (1.96)*   (0.12)    
risk2_uncertainty    0.807   -0.503    
    (1.23)   (0.62)    
risk2_health  check    0.650   0.151    
    (2.18)**  (0.47)    
risk2_religion    -0.799   -0.858    
    (1.25)   (1.18)    
risk2_trust    -0.346   -0.045    
    (0.44)   (0.22)    
Worker      -271.764 -250.159 -241.520  -0.066 
     (2.07)**  (1.56)  (2.15)**  (0.47) 
Smoking      205.419 257.786 101.575  0.009 
      (1.50) (1.57) (0.89)  (0.06) 
Fincome      0.010 0.013 0.005  0.311 
      (1.31) (1.48) (0.93) (2.98)*** 
Education     224.738  482.622  98.078  0.585 
     (0.91)  (2.37)**  (0.45)  (2.07)** 
Rcancer      595.629 531.328 507.543  0.582 
     (1.90)*  (1.43)  (1.91)*  (2.39)** 
Uncertainty      -224.828 -340.606 -158.991  -0.452 
     (1.69)*  (1.85)*  (1.29)  (2.01)** 
Health check      -33.921  9.362  -67.210  0.229 
      (0.26) (0.06) (0.62)  (1.64)* 
Religion     -177.525  -431.596  54.066  0.061 
     (0.91)  (1.70)*  (0.24)  (0.24) 
Trust      401.842 368.080 403.771  0.425 
     (2.82)***  (2.19)**  (3.40)***  (2.99)*** 
Constant      -330.964 -599.908 -164.013  0.602 
      (0.87) (1.51) (0.53)  (0.61) 
Observations  833  833  833 833 833  833 
Log-likelihood  -7378.16  -7350.87  -7099.72 -7295.66 -7304.20  -1748.22 
R-squared  -0.14  -0.08  0.05 0.06 0.04  0.06 
Typical person’s WTP-risk coefficient   
Constant 0  0  785.886  738.3830  762.3307  4.9817 
Level term  28.2843  81.0879  -0.9486  11.8542  2.4805  0.0199 
Squared term  0  -1.2815  0  -0.2464  -0.0882  -0.0003 
Marginal WTP (Yuan)  282,843  810,879  -9,486  72,616  8,366  25,787 
Average WTP  (Yuan)  282,843  572,023  833,824  794,692  834,589  183,385 
Robust t statistics in parentheses.  significant at 15%, * significant at 10%, ** significant at 5%; *** significant at 1%. 
R=9,3194, WTP=180,2293,  
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WTP Model  
(Model 4) 










0  59,900  +  29,469  + 
0.1 59,770  70,736,835  29,485  12,841,895 
0.5 59,250  14,194,975  29,549  2,591,993 
1 58,600  7,126,950  29,624  1,310,790 
5 53,400  1,470,190  30,035 286,044 
7.5 50,150  997,385  30,109 200,724 
10 46,900  760,170  30,032 158,064 
15 40,400  521,330  29,401 115,300 
20 33,900  400,285  28,103  93,677 





Table A.1 Cancer incidence rate  
(per 10,000 a year, average of 1993-1997) 
Age 
ranges  National average  Jiangsu  Tianjin 
 Male  Female  Male  Female Male Female 
TOTAL 24.78  19.38  25.69 13.54 24.52 20.49 
0_4  1.28 0.90 0.62 0.20 1.41 1.18 
5_9  0.97 0.78 0.88 0.56 1.01 1.14 
10_14  1.06 0.79 0.76 0.53 1.29 0.63 
15_19  1.11 0.84 0.77 0.55 1.34 0.76 
20_24  1.33 1.59 1.15 0.83 1.29 1.88 
25_29  2.03 2.47 2.92 1.55 1.62 2.80 
30_34  3.67 4.68 8.23 3.98 2.84 4.81 
35_39  7.11 8.65  18.64 7.96 5.03 7.19 
40_44 12.93  13.14  31.65 16.42 11.09 11.03 
45_49 19.57  19.10  45.55 22.13 19.92 17.71 
50_54 28.94  24.62  43.69 23.39 31.68 26.58 
55_59 40.84  34.88  59.83 27.73 40.44 44.30 
60_64 75.68  53.77  93.69 39.65 76.38 64.52 
65_69  112.53 69.40  114.45 48.66  123.23 80.11 
70_74  151.01 89.10  134.68 55.79  178.94 98.49 
75_79  164.10 97.63  149.87 72.04  183.12  107.65 
80_84  153.46 92.79  102.43 40.19  182.95 99.55 
85  106.89 79.35 --  --  130.89 78.41 
1.  Data Source : Data for Tianjin and Jiangsu come from Parkin, D.M., S.L. Whelan, J. Ferlay and H. Storm (2005). 
Cancer Incidence in Five Continents, Volumes I to VIII. International Agency for Research on Cancer and the 
World Health Organisation. IARC CancerBase No 7, Lyon, 2005. Website : http://www-dep.iarc.fr/ 
2.  Data for national average are calculated by authors according to the IRAC database. 
 
Table A.2 National average cancer mortality rate
1 (per 10,000 persons) 
 1991  1995
2 2000 
Age rage  male   female   male   female   male   female  
15-44 3.12  2.00  3.26  2.00  3.29  2.13 
45-54 22.32  12.62  23.49  13.19  24.3  14.14 
55-64 56.23  28.33  48.97  25.41  47.7  26.30 
65-74 104.27  53.10  93.18  38.10  104.89  51.58 
75+ 128.24  67.84  126.99  67.29  135.39  67.39 
1.  the data for 1991 and 2000 come from Yang, L., DM Parkin, LD, Li, YD, Chen and F. Bray (2004): Estimation and projection of 
the national profile of cancer mortality in China: 1991-2005. British Journal of Cancer (2004) 90, 2157-2166. 
2.  The data for year 1995 is projected by authors. We suppose a linear growth for both the cancer incidence and population between 
1991 and 2000. 
3.  This data also used in mortality rate estimation reported in table 7. 
 
Table A.3 Province-specific cancer incidence rate used in estimation 
(per 10000 persons) 
Age ranges  National average  Jiangsu  Tianjin 
 Male  Female  Male  Female Male Female 
15_44  5.20  6.09  10.484 4.995 4.205 5.210 
45_55 23.55  21.39  44.730 22.668 24.800 21.446 
55_65 58.13  44.45  75.832 33.466 58.331 54.173 
65_75  128.46  77.78 122.593  51.193 145.114  85.854 
75+  151.92  93.35 116.020  51.852 174.414  97.546 
1.  calculated directly by authors from the IRAC database f with a less precise age-classification.  
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Table A-4 Ranges of VSL estimates by countries, 2006 USD 




Transport Environment  Other  Total Mean  Median 
Australia 17  0.9-2.2  2.2-21.1  1.3-5.4  0.7-5.3  1.1-13.1  0.7-21.1 4.2  2.2 
Austria 5  ---  1.9-9.8  ---  ---  4.0-9.8  1.9-9.8 6.7  6.1 
Canada 17  2.0-6.7  0.6-5.8  0.5-30.5  ---  2.7-10.8  0.5-30.5 5.4  3.7 
Demark 2  ---  ---  1.0-1.4  ---  4.9-6.5  1.0-6.5 3.2  3.2 
Europe 1  ---  ---  4 --- ---  4 4.0  4.0 
France 2  ---  ---  1.1-26.6  ---  3.8-5.4  1.1-26.6 8.8  8.8 
Hong Kong  1  ---  2  ---  ---  ---  2 2.0  2.0 
Japan 4  ---  11.4-15  ---  ---  6.1-9.1  6.1-15.0 11.9  13.2 
New Zealand  10  ---  ---  0.8-15.9  ---  2.1-3.1  0.8-15.9 5.2  3.9 
South Korea  6  ---  1.0-1.9  ---  ---  0.5-1.0  0.5-1.9 1.2  1.1 
Sweden 7  ---  ---  1.6-32.7  ---  1.6-5.0  1.6-32.7 5.9  4.2 
Switzerland 5  ---  7.4-10.1  1.0-1.3  ---  5.4-9.6  1.0-10.1 5.0  5.7 
Taiwan 7  ---  0.2-2.2  ---  ---  1.0-1.4  0.2-2.2 1.3  1.3 
UK 26  ---  1.6-8.7  0.7-25.2  23.3  1.0-30.7  0.8-86.8 13.0  6.5 
US 117  0.2-8.7  0.4-24.4  0.15-37.7  0.8-10.1  0.7-31.4  0.1-37.7 6.7  5.3 
Multiple 17  ---  0.4-22.3  0.15-37.7  0.07-98.7  0.5-62.9  0.1-98.7 9.9  5.6 
All 244  0.2-6.5  0.2-86.8  0.15-37.7  0.07-98.7  0.5-62.9  0.1-98.7  7.0  4.9 
Mean ---  3  8.2  5.9  8.3  6.3  7  ---  --- 
Median ---  2.7  5.5 4  6  4.5 4.9  ---  --- 
Source: Australian Safety and Compensation Council (2008). The initial table is in Australian Dollar (2006 price). The authors have 
converted the VSL value into 2006 US dollar, with the  corresponding historical exchange rate 1 Australian dollar=0.742302 US dollar. 
 